Drugs, Poisons and Controlled Substances (Precursor Chemicals) Regulations 2017

The central concept is the “precursor chemical” as defined in regulation 5. The definition is extremely broad. It means a substance (including its salts, derivatives, isomers, analogues and homologues) that may be used in the preparation of a drug of dependence, whether or not the substance is contained in, or mixed with, another substance. Three features of this definition deserve close attention.

First, the inclusion of “derivatives, isomers, analogues and homologues” means that the regulation is not limited to the exact chemical names listed in Schedule 1. A compound that is structurally related to a scheduled chemical may itself be caught, even if not expressly named. This creates significant legal uncertainty for anyone handling chemicals that are close relatives of scheduled substances. There is no de minimis exception for distant analogues or for substances that have no practical use in drug manufacture; the only limiting factor is whether the substance “may be used” in the preparation of a drug of dependence. That phrase is not defined and could be read very broadly - it would cover any substance that is theoretically capable of being used, even if its main commercial application is entirely legitimate. A business importing industrial solvents must therefore assess not only the named chemicals but also their analogues and homologues, a task that may require specialised chemical knowledge and legal interpretation.

Second, the definition explicitly covers mixtures. A substance is a precursor chemical even if it is contained in or mixed with another substance. This means that a bottle of cleaning fluid containing ammonia at a low concentration is still a precursor chemical mixture. The quantity threshold, however, is expressed in the schedule column heading as “Quantity of mixture of substance and prescribed precursor chemical”. That wording is ambiguous. It is not clear whether the threshold refers to the mass of the pure precursor chemical content, or to the total mass of the mixture (including any diluents). For example, if a chemical has a threshold of 150 grams, and it is present in a 10% solution, does the threshold apply when the solution mass reaches 150 grams (meaning only 15 grams of pure chemical) or when the pure chemical content reaches 150 grams (meaning 1500 grams of solution)? The column heading appears to say “Quantity of mixture of substance and prescribed precursor chemical”, which implies the total mixture mass. Yet the schedule lists only the chemical name, not the mixture name. This drafting obscurity is a trap for the unwary and may lead to inconsistent enforcement.

The third concept is the prescribed quantity itself. Each chemical has a unique threshold. Many thresholds are low enough to capture small-scale legitimate activities. For example, ergometrine and lysergic acid each have a threshold of 0.005 grams (5 mg). A researcher holding a few milligrams of ergometrine as a laboratory standard could inadvertently exceed the threshold. Other thresholds such as mercury (0.1 grams), palladium (0.5 grams), and platinum oxide (0.5 grams) are also very low. These low thresholds impose a compliance burden even on bona fide users who handle minute quantities for analytical or research purposes. At the same time, some thresholds are relatively generous: anthranilic acid at 500 grams, phenylacetic acid at 50 grams, and pyridine at 100 grams. The variety of thresholds reflects the regulators’ assessment of the danger of diversion, but it also creates a complex compliance environment where each substance must be tracked separately against its own threshold.

The regulations affect any person or business in Victoria who manufactures, possesses, sells, supplies, or uses any substance falling within the broad definition of a precursor chemical, and who does so in quantities that may exceed the prescribed thresholds. This includes a wide range of industries and activities far beyond clandestine drug laboratories.

Chemical manufacturers, distributors, and importers are the primary targets. They routinely handle large quantities of industrial chemicals such as acetic anhydride (threshold 100 grams), ammonia (150 grams), formaldehyde (150 grams), hydrogen (150 grams), and iodine (25 grams). Any company that warehouses or supplies these substances must have a system to track both the identity and the quantity of each chemical, and to determine whether the threshold has been reached across its entire inventory. The fact that the definition includes mixtures means that diluted solutions also count. A supplier of 20-litre drums of 28% ammonia solution (approximately 5.6 kg of pure ammonia) would exceed the 150-gram threshold many times over. That supplier must hold the appropriate authorisation under the parent Act or risk prosecution.

The pharmaceutical and veterinary industries are particularly exposed. Many scheduled substances are common pharmaceutical ingredients: ephedrine (threshold 25 grams), pseudoephedrine (25 grams), phenylpropanolamine (25 grams), ergometrine (0.005 grams), and lysergic acid (0.005 grams). Pharmacies that prepare compounded medicines, or that stock raw pharmaceutical ingredients, must ensure that their holdings do not exceed the thresholds without a licence. Over-the-counter cold and flu medications containing pseudoephedrine are already subject to separate controls under state and federal poisons laws, but the regulations add an additional layer: if a pharmacy accumulates more than 25 grams of pure pseudoephedrine (across all products, including mixtures), the stockholding may trigger the precursor regime. Given that a single packet of 24 tablets at 60 mg each contains 1.44 grams, a pharmacy would need only about 18 packets to exceed the threshold. That is not an unrealistic inventory for a busy pharmacy.

Laboratories and research institutions are directly affected. Many scheduled chemicals are standard reagents: acetone (not listed), but many others such as benzaldehyde (50 grams), phenylacetic acid (50 grams), formaldehyde (150 grams), and piperidine (5 grams) are common. Researchers working with even moderate quantities of these substances must verify whether their cumulative holdings exceed the thresholds. The low thresholds for noble metal catalysts such as palladium (0.5 grams) and platinum (0.5 grams) mean that a single vial of palladium on carbon catalyst, often sold in 1-gram or 5-gram quantities, could breach the threshold. University chemistry departments and analytical laboratories must maintain meticulous inventory records and link them to the regulatory thresholds.

Small businesses and tradespeople are inadvertently caught. Hardware stores that sell ammonia as a cleaning agent, or that stock iodine as a disinfectant, may stock quantities above the thresholds. Welding supply businesses handling hydrogen or calcium (threshold 25 grams) may be affected. The regulations do not exempt consumer or industrial uses; the only defence is authorisation under the parent Act. The compliance burden falls disproportionately on smaller businesses that lack the legal and compliance resources of large chemical companies.

Individuals with home chemistry hobbies, or those who possess laboratory equipment for legitimate science education, are also affected. While such individuals are unlikely to hold large quantities of most substances, the very low thresholds for some chemicals (ergometrine, lysergic acid, mercury) mean that even a small personal collection could be illegal without authorisation.

The regulations themselves impose no duties and confer no rights. They are purely definitional. The duties and rights arise from section 71D of the Drugs, Poisons and Controlled Substances Act 1981 and related provisions of that Act. Without seeing the exact text of section 71D, the standard structure of such provisions is that a person must not manufacture, possess, sell, supply, or use a prescribed precursor chemical without a licence, permit, or other authority from the relevant government agency, if the quantity exceeds the prescribed amount. The regulations therefore determine the threshold at which that duty is triggered.

The key practical duty for anyone handling scheduled chemicals is to ascertain whether their current holdings (including stocks in transit, in storage, and in use) exceed the prescribed quantities. If they do, the person must ensure they hold the requisite authorisation under the parent Act. If they do not hold such authorisation, they must reduce their holdings below the threshold or apply for the appropriate permit or licence. The regulations do not provide a grace period or transitional arrangement; they take effect immediately upon the revocation of the 2007 regulations.

The definition of precursor chemical in regulation 5 is so broad that it creates a duty of inquiry: a person must determine whether any substance they handle is a “salt, derivative, isomer, analogue or homologue” of a listed chemical. This is a significant burden because it requires chemical knowledge and legal judgment. An importer of a compound that is a homologue of a listed chemical cannot simply rely on the name not appearing in the schedule; the duty may still apply if the substance falls within the definition. The practical response is to conduct a chemical review of every substance handled and compare it to the schedule’s chemical families.

Rights under the regulations are minimal. A person who is aggrieved by a decision of an authorised officer or the relevant Minister regarding the application of the regulations or the parent Act may have review rights under the parent Act or under general administrative law, but those rights are not created by this instrument. The only right expressly conferred by the regulations is the right to rely on the schedule as definitive: if a chemical is not listed and is not an analogue or derivative of a listed chemical, it is not a prescribed precursor chemical for the purpose of section 71D.

The regulations contain no penalty provisions. All penalties, enforcement powers, and procedures are located in the Drugs, Poisons and Controlled Substances Act 1981. Typically, such Acts create criminal offences for breaching their provisions, with penalties ranging from fines to imprisonment, depending on the seriousness of the offence. Because section 71D is a critical element in the control of drug precursors, it is likely that the penalties are substantial.

Enforcement is carried out by Victoria Police, authorised officers from the Department of Health, and possibly other agencies. The parent Act likely confers powers of entry, search, seizure, and inspection on authorised officers. These powers are significant because they can be exercised without a warrant in certain circumstances, such as where there are reasonable grounds to suspect an offence. The regulations set the factual parameters of the offence; enforcement action will turn on whether a person possessed or dealt with a quantity of a scheduled chemical above the threshold without authorisation.

The broad definition of precursor chemical creates enforcement challenges. An officer must determine whether a seized substance is a “derivative, isomer, analogue or homologue” of a listed chemical. This may require expert chemical analysis and legal interpretation. In practice, enforcement may focus on the clearly listed chemicals and on circumstances that suggest an intent to manufacture drugs of dependence. However, the letter of the law is wider than that, and a business that inadvertently breaches the threshold because of the broad definition may still be liable.

Because the regulations are delegated legislation, any ambiguity in the definition or the quantity thresholds is likely to be resolved in favour of the Crown. The burden of proof in a criminal prosecution would be on the prosecution to establish all elements of the offence, including that the substance falls within the definition and that the quantity exceeded the prescribed amount. The ambiguous column heading regarding mixtures may become a litigated issue. Until then, the regulatory authority is likely to take the view that the quantity refers to the total mass of the mixture containing the precursor, not the pure chemical content.

The regulations do not operate in isolation. They are part of a layered regulatory framework that includes state and Commonwealth laws.

At the state level, they are made under the Drugs, Poisons and Controlled Substances Act 1981 and are incorporated into that Act’s scheme for controlling drugs of dependence and their precursors. The parent Act also contains provisions for the regulation of poisons, controlled substances, and other chemicals. A person holding a licence under that Act for one purpose (for example, a pharmacist’s licence to supply poisons) may need a separate authorisation to handle precursor chemicals above the prescribed quantities. The regulations do not create any exemptions or harmonisation with other parts of the Act.

The regulations may also interact with the Victorian Drugs, Poisons and Controlled Substances Regulations (other than the precursor chemicals regulation), such as the main poisons regulations that control the supply of scheduled poisons. For example, pseudoephedrine is both a precursor chemical under these regulations and a Schedule 4 poison under the poisons code. A pharmacy must comply with both regimes: the restrictions on supply of Schedule 4 medicines and the prohibition on possessing more than 25 grams of pseudoephedrine without authorisation under the precursor regime. The two sets of requirements may impose redundant but slightly different record-keeping and reporting obligations.

At the Commonwealth level, the importation, exportation, and manufacture of many precursor chemicals are controlled under the Customs (Prohibited Imports) Regulations and the Criminal Code 1995 (Cth). The Commonwealth controls may set different quantity thresholds or different definitions. A business importing a chemical that is listed under both regimes must comply with both sets of obligations. There is no automatic mutual recognition; a Commonwealth permit does not obviate the need for a Victorian licence, and vice versa. This dual regulation increases compliance costs, particularly for businesses that operate across state and federal borders.

The regulations also interact with workplace health and safety and dangerous goods legislation. Many of the listed chemicals are hazardous (e.g., hydrogen, ammonia, formaldehyde, thionyl chloride). Employers must comply with the Occupational Health and Safety Act 2004 (Vic) and the Dangerous Goods (Storage and Handling) Regulations 2022 (Vic) regarding storage, labelling, and safety data sheets. These requirements are separate from the precursor regime, but they often require the same kind of inventory tracking and management. A business that already maintains a dangerous goods register can use that register to also monitor compliance with the precursor threshold requirements. However, the two regimes have different definitions and different quantity triggers, so a single database must be able to manage both.

The sunset clause in the regulations (10 years from 18 July 2017) means that they will expire on 18 July 2027 unless remade. This creates uncertainty for long-term planning. Businesses that invest in compliance systems that depend on the current list of chemicals may face a change in the regulatory environment when the regulations are remade or allowed to lapse. If they lapse, section 71D of the parent Act would have no prescribed precursor chemicals or quantities, effectively deactivating that provision until new regulations are made. This could create a regulatory gap.

The Drugs, Poisons and Controlled Substances (Precursor Chemicals) Regulations 2017 were made on 18 July 2017, came into operation on 21 July 2017, and revoked the Drugs, Poisons and Controlled Substances (Precursor Chemicals) Regulations 2007 (S.R. No. 84/2007). As of the version published (Version No. 001), there are no amendments. The table of amendments in the endnotes confirms that no statutory rules, subordinate instruments, or Acts have amended these regulations. They are therefore in their original form.

The parent Act, however, may have been amended since 2017, and those amendments could affect the interpretation or application of the regulations. For example, if section 71D is amended to change the classes of conduct that are prohibited, or to add exemptions, the practical effect of the regulations would change even though the regulations themselves are unamended. The regulations are static; the parent Act is dynamic.

The revocation of the 2007 regulations is significant. Any person who had been complying with the 2007 list must have updated their compliance systems to reflect the 2017 list. The 2017 list includes several new chemicals that were not previously prescribed, such as (helional) 3-(1,3-benzodioxol-5-yl)-2-methylpropionaldehyde, methyl 3-[3'4'-(methylenedioxy)phenyl]-2-methyl glycidate, alpha-methyl-3,4-methylenedioxyphenylpropionamide, and sodium 2-methyl-3-(3,4-methylenedioxy)phenyl glycidate. These additions likely reflect the evolution of drug manufacturing techniques, particularly for MDMA and other amphetamine-type substances. Businesses that previously handled these chemicals without authorisation because they were not prescribed would have needed to obtain authorisation or cease handling them after 21 July 2017.

The regulations also made adjustments to quantities for some chemicals from the 2007 schedule, but the source text does not reproduce the 2007 schedule for comparison. Without the old schedule, it is not possible to identify which specific quantities changed. However, the revocation of the old regulations and the making of the new ones means that the quantities in Schedule 1 of the 2017 regulations are the only operative quantities for section 71D.

The source text does not mention any litigation relating to these regulations. The endnotes contain no references to court cases. This likely reflects that the regulations are relatively new (commenced in 2017) and that litigation under delegated legislation of this kind is uncommon. Most prosecutions under section 71D are likely to be uncontested as to the identity and quantity of the precursor chemical; the contested issues typically would be whether the defendant had the requisite mental state (intent to manufacture a drug of dependence) or whether an authorisation existed.

However, the broad definition of “precursor chemical” in regulation 5 and the ambiguous column heading for quantities are potential sources of litigation. A person charged with an offence under section 71D might argue that the substance they possessed is not a salt, derivative, isomer, analogue, or homologue of a listed chemical, or that the quantity was calculated incorrectly because the prosecution used the mass of the pure chemical rather than the mass of the mixture. These arguments could be tested in the Magistrates’ Court of Victoria or in the Supreme Court of Victoria on judicial review. As of the version date, no such cases have been reported in the endnotes.

The lack of litigation history does not mean the regulations are risk-free. It may simply mean that enforcement agencies have focused on the clear cases - possession of large quantities of ephedrine or pseudoephedrine - where the facts fall squarely within the listed chemicals and the quantities are indisputable. Smaller-scale or borderline cases may be dealt with by warning or official caution rather than prosecution. The threat of litigation remains for any person who falls within the grey areas of the definition.

The regulations contain several traps that a diligent practitioner should highlight.

The broad definition of precursor chemical is the most significant. It includes salts, derivatives, isomers, analogues, and homologues. A person who checks only the list in Schedule 1 and concludes that a substance is not regulated may be wrong if the substance is an analogue of a listed chemical. For example, if a business handles a homologue of a listed chemical that is not itself listed, it may still be a precursor chemical. The absence of a bright-line test means that legal and chemical expertise is required to determine whether a substance is captured. This imposes a compliance cost that is not apparent from a simple reading of the schedule.

The quantity column heading is ambiguous. The heading reads “Quantity of mixture of substance and prescribed precursor chemical”. This appears to indicate that the quantity refers to the total mass of the mixture that contains the precursor, not the pure precursor mass. However, that interpretation leads to absurd results: a 10% solution of piperidine would have a threshold of 5 grams of mixture (0.5 grams of pure piperidine), while a 100% pure sample would have a threshold of 5 grams. The lower the concentration, the lower the mass of mixture needed to trigger the threshold. This could mean that a dilute solution is more tightly controlled than a concentrated one, which is counterintuitive. It is also unclear whether the mixture mass includes the container or only the contents. The better view - and the view most enforcement agencies are likely to take - is that the quantity refers to the mass of the precursor chemical itself (the pure substance), and the column heading is poorly drafted. But until this is clarified by official guidance or a court decision, a risk-averse person should assume the worst and treat the threshold as applying to the total mass of any mixture containing the precursor.

The inclusion of mixtures in the definition of precursor chemical means that a substance that is present in a product at low concentration is still a precursor chemical. But the quantity is computed on the mixture mass if the column heading is taken literally. This creates a trap for manufacturers of consumer goods. For example, a cleaning product containing 5% ammonia (by mass) in a 1-litre bottle weighs approximately 1 kg, containing 50 grams of ammonia. Under the 150-gram threshold for ammonia, if the threshold is measured on the mixture mass, then the 1 kg bottle (a mixture) would exceed the threshold (150 grams total mixture) even though the pure ammonia content is only 50 grams. That would mean that a single bottle of household ammonia cleaner could be a prohibited precursor chemical above the threshold. That is likely not the intended result, but the text allows it. A business producing or importing such products would be well advised to seek a legal opinion or apply for an exemption.

The very low thresholds for some substances are another trap. Ergometrine and lysergic acid have a threshold of 0.005 grams (5 mg). A laboratory that holds a single vial of ergometrine maleate, perhaps weighing a few milligrams, may exceed the threshold if it has more than one vial or if other ergometrine-containing substances are present. Similarly, mercury (0.1 grams) - a few drops from a broken thermometer could be enough. Platinum and palladium catalysts (0.5 grams each) are commonly supplied in quantities of 1 gram or more. Any researcher who opens a new vial of catalyst and adds it to a reaction flask will immediately exceed the threshold if they do not have an authorisation.

The definition of precursor chemical does not include any exemption for substances that are in a form or concentration that makes them unsuitable for drug manufacture. The only relevant factor is that the substance “may be used” in the preparation of a drug of dependence. This is a low bar. A cleaning solution of ammonia may be used to prepare a drug of dependence, even though that is not its intended use. Theoretically, almost any chemical that can undergo a chemical transformation could be “used in the preparation” of a drug of dependence; the phrase is not limited to direct precursors. The only limiting factor is that the substance must be a precursor chemical (a substance). Almost all organic compounds could be used in some chemical pathway to prepare a drug of dependence, making the definition potentially limitless. In practice, enforcement is likely to be reasonable, but the black letter of the law is alarmingly broad.

The sunset clause creates regulatory uncertainty. The regulations expire in 2027. A business that relies on the current list for its compliance system may need to update its system if the regulations are remade with a different list. If the regulations are not remade, section 71D becomes inoperative, which would be a welcome development for businesses but an unwelcome one for law enforcement. Businesses should monitor the regulatory environment and plan for the sunset.

Compliance begins with a comprehensive audit of all chemicals held, used, or supplied by the business or individual. The audit should identify every substance and its chemical identifier (CAS number or IUPAC name) and compare it against Schedule 1. However, because the definition includes salts, derivatives, isomers, analogues, and homologues, the audit must go beyond simple name matching. It is prudent to review the chemical structure of each substance and assess whether it is a close structural relative of any listed chemical. This may require assistance from a chemist or a drug control specialist.

For each identified precursor chemical, the total quantity held across all locations, in all forms (including mixtures, solutions, and wastes), must be calculated. The quantity should be determined as the mass of the pure precursor chemical content (the conservative approach) or as the mass of the mixture (the literal approach under the column heading). Given the ambiguity, the safest approach is to treat the threshold as applying to the mass of the pure precursor chemical but also to keep the mixture mass below the threshold if feasible. If total quantity exceeds the threshold, the person must immediately confirm that they hold a valid authorisation under the parent Act (a licence, permit, or exemption). If no authorisation exists, they must either reduce holdings below the threshold or apply for the necessary authorisation. It is not advisable to rely on the possibility that the threshold applies only to the mixture mass, as enforcement agencies may take a different view.

Record keeping is critical. The parent Act likely requires detailed records of acquisition, use, storage, and disposal of precursor chemicals. Even if the regulation does not specify record-keeping, a person defending against a charge of unauthorised possession would benefit from records that demonstrate the quantity fell below the threshold or that the substance is not a precursor chemical. A written policy that includes a list of all scheduled chemicals handled, the maximum quantities held, the authorisation numbers, and the procedures for ensuring quantities never exceed thresholds is a practical step.

For businesses that handle multiple products containing the same precursor (e.g., a pharmacy with multiple brands of pseudoephedrine-containing medications), the total pure precursor content must be aggregated. A spreadsheet or inventory management system that tracks the pure chemical content of each product is essential. The threshold for pseudoephedrine is 25 grams; a pharmacy should ensure that its total stock of pseudoephedrine (including in compounded preparations and raw ingredients) never exceeds that amount without a licence.

Employees and managers should be trained on the regulations. They should understand that the list is not exhaustive; that analogues and derivatives are caught; that mixtures count; and that the quantities are absolute thresholds, not limits per transaction. A common mistake is to assume that a small quantity held for personal use is exempt. The regulations provide no exemption for personal use. Any quantity above the threshold requires authorisation.

Given the complexity and the legal risks, obtaining professional legal advice is recommended. A lawyer specialising in Victorian drug control law can advise on the application of the regulations to specific facts, assist with licence applications, and represent the client in the event of an investigation. Compliance is not simply a matter of checking the schedule; it requires an understanding of the parent Act, the definition, and the enforcement practices of the relevant agencies.

Finally, monitor the sunset date. The regulations will expire on 18 July 2027 unless new regulations are made. Businesses should participate in any consultation process for the remaking of the regulations to ensure that the new list is workable and that any ambiguities in the current regulations are addressed. Planning for the transition should begin at least a year before the sunset.